GlassScriptPhysician profile
Kevin Tong
NPI 1225410293
$3,109.11
in general payments reported to CMS, 2019-2025
11 companies · $1,152 in 2025
The $1,152 reported for 2025 was more than what 93% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.34 · 2021: $158 · 2022: $494 · 2023: $646 · 2024: $560 · 2025: $1,152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,258 · Entertainment: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,257.73 |
| Entertainment | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,100.94 | 2022-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $657.07 | 2022-2025 | Miebo, Lotemax Sm, Vyzulta |
| Glaukos Corporation | $326.56 | 2022-2024 | Gts100_glaukos Istent Trabecular Micro-Bypass Stent System |
| Alcon Vision LLC | $249.12 | 2023-2025 | Clareon, Precision 7, Precision7 |
| Coopervision INC. | $148.38 | 2021-2025 | Myday Contact Lens, Misight Contact Lens |
| Biotissue Holdings INC. | $125.13 | 2023 | |
| Sun Pharmaceutical Industries INC. | $125.00 | 2021 | |
| Optos, INC. | $100.00 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $99.34 | 2019 | |
| Mallinckrodt Hospital Products INC. | $91.62 | 2025 | Acthar |
| Carl Zeiss Meditec USA, INC. | $85.95 | 2023 | Clarus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Tong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.